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The neural crest is an excellent model system for the study of cell type diversification during embryonic development due
to its multipotency, motility, and ability to form a broad array of derivatives ranging from neurons and glia, to cartilage,
bone, and melanocytes. As a uniquely vertebrate cell population, it also offers important clues regarding vertebrate
origins. In the past 30 yr, introduction of recombinant DNA technology has facilitated the dissection of the genetic
program controlling neural crest development and has provided important insights into gene regulatory mechanisms
underlying cell migration and differentiation. More recently, new genomic approaches have provided a platform and
tools that are changing the depth and breadth of our understanding of neural crest development at a ‘‘systems’’ level. Such
advances provide an insightful view of the regulatory landscape of neural crest cells and offer a new perspective on
developmental as well as stem cell and cancer biology.
The neural crest is an embryonic cell populationwith stem cell-like
properties, including multipotency and the ability to self-renew.
Unique to vertebrates, neural crest cells contribute to awide variety
of derivatives, including sensory and autonomic ganglia of the
peripheral nervous system, adrenomedullary cells, cartilage and
bone of the face, and pigmentation of the skin. Although similar
cell types, such as pigment cells and sensory neurons, already exist
in nonvertebrate chordates and other multicellular organisms,
these derivatives arise de novo under the umbrella of the neural
crest in the vertebrate lineage.
Since its discovery byHis (1868), the neural crest has occupied
a prominent place in developmental biology due to its extensive
migratory properties and remarkable developmental potential.
Interest in this cell population has been further fueled by its
medical and evolutionary importance. For example, numerous
congenital birth defects and neoplastic diseases are linked to ab-
normal development of the neural crest development and its
derivatives (Hall 1999). Due to its inherent stem cell properties,
there is great interest in using these cells in regenerativemedicine
to treat disorders like familial dysautonomia, cleft palate, and
some heart conditions ( Jones and Trainor 2004; Lee et al. 2009).
Furthermore, as the neural crest gives rise to a number of verte-
brate-specific traits, it is thought to have played an important role
in chordate evolution (Gans and Northcutt 1983; Northcutt
2005).
The initial phases of neural crest formation include some of
the most extensive morphogenetic movements observed during
vertebrate embryonic development (Fig. 1). Initially the prospec-
tive neural crest cells reside in a territory known as the neural plate
border, which is located at the edges of the neural plate, the em-
bryonic region destined to form the central nervous system.
Through a process called neurulation, the neural plate invaginates
by elevation of the edges, or neural folds. The end result is the
conversion of the flat neural plate into a cylindrical structure called
the neural tube, which will later form the brain and spinal cord.
During the process of neural tube closure, premigratory neural
crest cells reside first within the neural folds as they converge
toward the midline and then in the dorsal aspect of the neural
tube. Shortly thereafter, they lose their intercellular connections,
undergo an epithelial to mesenchymal transition (EMT), and ac-
quire mesenchymal, migratory characteristics that endow these
cells with the ability to leave the neural tube (Gammill and Bronner-
Fraser 2003; Sauka-Spengler and Bronner-Fraser 2008b).
Once they have emigrated from the neural tube, neural crest
cells migrate in organized streams to populate different niches
throughout the embryo. Depending upon their starting position
along the body axis and the subsequent path taken, they give rise
to different cell types and contribute to the formation of a variety
of tissues and organs (Fig. 2). The cranial neural crest forms a large
portion of the facial skeleton as well as cranial ganglia, smooth
muscle, and pigment cells. The vagal neural crest has an important
role in cardiac development since it contributes to the valves and
septa of the heart and also forms the enteric nervous system that
innervates the entire length of the gut. The trunk neural crest gives
rise to dorsal root and sympathetic ganglia of the peripheral ner-
vous system, as well as secretory cells andmelanocytes. Finally, the
neural crest formed at the sacral region cooperates with the vagal
crest to form a small portion of the enteric nervous system (Le
Douarin 1986; Le Douarin and Kalcheim 1999). Although neural
crest cells appear to become progressively restricted as they reach
particular targets, many earlymigrating cells are multipotent, with
the ability to form several derivatives (Bronner-Fraser and Fraser
1988, 1989).Moreover,manyneural crest-derived tissues appear to
retain neural crest stem cells that are multipotent (Crane and
Trainor 2006).
A number of classical experiments were fundamental for
understanding the main characteristics of the neural crest. For
example, early studies with amphibian embryos suggested that
there was regionalization of neural crest populations along the
body axis and broad developmental potential (Horstadius 1950).
Importantly, the elegant quail-chick chimera experiments pio-
neered by Nicole Le Douarin in the 1960s and 1970s were central
in defining the precise contributions of different populations of
the neural crest to distinct derivatives in higher vertebrates (Le
Douarin and Kalcheim 1999). Bronner-Fraser and Fraser (1988)
tackled the question of the developmental potential of individual
neural crest by labeling single premigratory cells with a vital dye.
They showed that the progeny of a single neural crest cell included
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cell types as diverse as sensory neurons, presumptive pigment cells,
ganglionic supportive cells, and neural tube cells (Bronner-Fraser
and Fraser 1988). Clonal analysis of the neural crest in tissue cul-
ture further demonstrated multipotency of single neural crest
cells to form multiple derivatives (Sieber-Blum and Cohen 1980;
Trentin et al. 2004; Dupin et al. 2010) as well as their ability to self-
renew (Stemple and Anderson 1992). However, the presence of
some clones that formed single derivatives has been interpreted
as suggesting a possible fate restriction in some subpopulations
(Stemple and Anderson 1992). These and innumerous other ex-
periments have characterized cellular properties of the neural
crest that can now be tackled in molecular terms due to advances
in molecular biology and genomics.
In the last three decades, advances in recombinant DNA
technology and molecular genetics techniques have made it pos-
sible to start examining the genetic program controlling neural
crest development. Identification of a number of tissue-specific
transcription factors allowed for the description of the first regu-
latory interactions necessary for establishment of neural crest
identity. Studies in several model organisms have provided
a wealth of molecular data that has helped to formulate our views
on how complex processes such as induction, specification, dif-
ferentiation, and migration are regulated. This extensive body of
work has established the neural crest as a prime model for the
exploration of questions central to developmental biology—such
as how complex and diverse tissues arise from a seemingly ho-
mogeneous population of cells.
Currently, genomic approaches are being used to address es-
sential aspects of neural crest development. The extensive work
done on the signaling and transcriptional control of neural crest
development culminated with the assembly of a gene regulatory
network that attempts to explain, in molecular terms, the process
of neural crest formation. Sequencing of chordate genomes has
allowed for identification of novel genes involved in neural crest
formation and provided numerous tools to scrutinize the regula-
tory mechanisms underlying this process. Furthermore, compar-
ative genomic analyses are providing important insights about the
evolution of the neural crest and the origins of the vertebrate clade.
Here, we will present a synopsis of the current state of the field of
neural crest biology from a gene regulatory perspective and will
also discuss how recent technological advances can help shape
future research.
Overview of the current state of the neural crest gene
regulatory network (GRN)
The regulatory machinery controlling neural crest formation and
diversification is comprised of an intricate array of transcription
factors and signaling molecules that act in concert to provide this
cell population with its defining features (Sauka-Spengler and
Bronner-Fraser 2008b). In order to interrogate such a complex
regulatory program, we and others have assembled a multistep
neural crest GRN that integrates transcriptional inputs and di-
verse environmental signals (Meulemans and Bronner-Fraser 2004;
Betancur et al. 2010a). A simplified version of the cranial neural
crest GRN is represented in Figure 3. It is composed of a series of
regulatory steps arranged hierarchically, which include induction
of the prospective neural crest, specification of the neural plate
border, specification of the bona fide neural crest cells, and the
diversification of the neural crest cells through the action of neural
crest effector genes (Sauka-Spengler and Bronner-Fraser 2008b).
Remarkably, these regulatory stages not only define cell identity
and behavior at a given time point, but also drive seamless tran-
sitions to the next regulatory state.
The first level of the neural crest GRN is comprised of in-
duction events that lead to the formation of the neural plate bor-
der. This process is dependent upon the interplay of different sig-
naling pathways such asWnt, Fgf, BMP, andNotch/Delta. Secreted
signaling molecules are produced by adjacent tissues and result in
the activation of a particular set of genes in the edges of the neural
plate. These neural plate border specifier genes (e.g.,Msx, Pax3/7,Zic1,
Dlx3/5) initiate expression prior to the traditional neural crest
marker genes and often are down-regulated once neural crest
identity is established. Their region of overlap at the neural plate
border defines a broad territory of cells competent to respond to
neural crest specifying signals and later formmigratingneural crest
cells (Meulemans and Bronner-Fraser 2004).
The next step in the neural crest GRN is initiated when neural
plate border specifiers in combination with signaling molecules
activate transcription of neural crest specifier genes. These include
transcription factors like Snai1/2, Tfap2a, Foxd3, Twist, Id, Myc,
and Sox9/10. Expression of these factors reflects the specification
Figure 1. Morphogenetic movements during early neural crest de-
velopment. (A) Schematic diagram of transverse sections through chick
embryo during neurulation. Prospective neural crest cells reside in the
neural plate border (green), a territory between the neural plate and the
non-neural ectoderm. (B) As neurulation proceeds, the neural plate in-
vaginates, resulting in the elevation of the neural folds, which contain
neural crest precursors. (C ) After neural tube closure, neural crest cells lose
intercellular connections and undergo an epithelial to mesenchymal
transition. Once they have delaminated from the neural tube, they mi-
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state of the neural crest population and endows them with its
defining features, like the ability to undergo EMT and become
migratory. Activation of the neural crest specifiers can be quite
complex and depends upon various inputs from all levels of the
neural crest GRN. For example, Snai2 activation requires co-
operation between elements of theWnt pathway, Zic1, and Pax3/7
(Sato et al. 2005). In addition, SoxE transcription factors are nec-
essary for the maintenance of snai2 expression (Honore´ et al.
2003). Thus, factors from different hierarchical levels of the neural
crest gene regulatory network operate in concert to establish and
maintain the neural crest transcriptional state (Sauka-Spengler and
Bronner-Fraser 2008b).
The neural crest specifier genes, in turn, regulate expression of
effector genes involved in cell cycle control, epithelial to mesen-
chymal transition, and migration. Neural crest effector genes jump-
start a number of gene batteries that instruct the behavior of the
newly formed neural crest cells, allowing them to delaminate from
the neural tube, proliferate and maintain population size, migrate
along different pathways, and finally differentiate into a wide va-
riety of derivatives (Meulemans and Bronner-Fraser 2004; Sauka-
Spengler and Bronner-Fraser 2008b). At the same time, the effector
genes activate the expression of receptors and signaling molecules
that equip the cells with the capacity to respond to environmental
cues. This molecular toolkit also allows cell–cell interactions that
influence not only other neural crest cells, but also numerous
embryonic tissues with which they interact during migration. For
example, neural crest cells instruct somite cells to differentiate into
muscle precursors (Rios et al. 2011).
The neural crest GRN integrates >20 yr of work from many
research groups performed in different model organisms, and
provides a conceptual framework for the study of the neural crest
genetic program. It is, however, not yet complete and will greatly
benefit from the high-throughput genomic approaches that are
currently part of the scientific repertoire. For instance, macroarray
screens have uncovered numerous new molecules that are up-
regulated in the neural crest (Gammill and Bronner-Fraser 2002;
Adams et al. 2008). Transcriptome analysis
of pure neural crest populations has un-
covered a variety of new specific transcrip-
tion factors, nuclear receptors and signal-
ing molecules that are expressed during
different stages of development (M Simo˜es-
Costa and ME Bronner, unpubl.). Further-
more, novel techniques for genome-wide
chromatin profiling allow genome-wide
identification of active and poised cis-
regulatory modules (Rada-Iglesias et al.
2012) and facilitate functional analysis for
rapid characterization of epistatic interac-
tions. Such approaches will increase the
complexity of the neural crest GRN by
providing a more accurate and complete
representation of the different regulatory
modules and their interactions.
The current version of the neural
crest GRN is grounded in interactions
between transcription factors and signal-
ingmolecules, and does not include extra
levels of regulation such as those im-
parted by epigenetic, post-transcriptional
and post-translational control. Neverthe-
less, there is increasing evidence pointing
to an important role for chromatin modification in the de-
velopment of the neural crest. For example, the histone demeth-
ylase JMJD2A directly regulates a number of neural crest specifier
genes, thus controlling the time of onset of their expression in the
neural folds (Strobl-Mazzulla et al. 2010). Furthermore, the neural
crest specifier, SNAI2, forms a complex with histone deacetylases
(HDACS) to silence genes such as CAD6B, thus allowing neural
crest delamination (Strobl-Mazzulla andBronner 2012). Epigenetic
silencing is also crucial for the initial demarcation of the neural
crest territory. Hu and colleagues have shown that DNA methyl-
transferase3A promotes neural crest specification by repressing
neural genes SOX2 and SOX3, thus acting as a fate switch in the
cells of the neuroectoderm (Hu et al. 2012). Recent results also
emphasize the role of post-translational modifications in neural
crest regulation. Lee and colleagues have shown that SUMOylation
of SoxE factors causes recruitment of the repressor Grg4 (also
known as Tle4) instead of its usual coactivator partners. This study
highlights how post-translational regulation can alter gene func-
tion and drive the same factor to play opposing roles in a context-
dependent manner (Lee et al. 2012).
At the present time, the neural crest GRN (Meulemans and
Bronner-Fraser 2004; Betancur et al. 2010a) primarily focuses on
the regulatory interactions of the cranial neural crest. Since im-
portant differences exist between distinct subpopulations of the
neural crest along the body axis (Le Douarin et al. 2004), it would
be naı¨ve to assume that such interactions are common to all
neural crest populations. Indeed, there are likely to be important
modifications that help explain regional differences in neural
crest cell migratory properties and cell fates (Simo˜es-Costa et al.
2012). Thus a more inclusive version of the GRN should include
the molecular circuits that are particular to each of the neural
crest subpopulations. Studies scrutinizing the regulatory states of
these distinct populations will reshape the GRN and provide
important clues about the plasticity of the neural crest. Ulti-
mately and optimally, the GRN will have predictive value, which
will help anticipate the molecular outcome of particular pertur-
Figure 2. Contributions of different neural crest cell populations to adult tissues and organs.
Depending on their axial level of origin and migratory pathway followed, neural crest cells adopt dif-
ferent fates and contribute to distinct tissues and organs. Cranial neural crest forms a large portion of
the facial skeleton as well as cranial ganglia, most of the dental tissues, and the cornea. Vagal neural
crest contributes to the valves and septa of the heart, the smooth muscle of the great vessels, and the
enteric nervous system. Trunk neural crest gives rise to dorsal root and sympathetic ganglia of the
peripheral nervous system and the chromaffin cells of the adrenal gland. Most caudally, the neural crest
formed at the sacral region contributes to a small portion of the enteric nervous system. Melanocytes of
the skin and integuments are derived from neural crest at all axial levels.
Genomic approaches in neural crest biology
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bations. This will be useful for etiological studies, of particular
importance due to the large number of neural crest-related birth
defects. A complete neural crest GRN will also inform upon ge-
netic reprogramming of induced pluripotent stem (iPS) cells or
embryonic stem (ES) cells into neural crest cells, which will have
significant implications for regenerative medicine and cancer.
Cis-regulatory analysis of neural crest enhancers
The first version of the neural crest gene regulatory network was
based on data assembled from a combination of gene expression
patterns and functional studies obtained from several model or-
ganisms (Meulemans and Bronner-Fraser 2004). Although this
approach provided a conceptual framework for investigating
neural crest identity, further resolution of the GRN requires the
identification of direct epistatic interactions among its players.
This can only be accomplished through
systematic identification and character-
ization of the cis-regulatory apparatus
that controls expression of specific com-
ponents of the neural crest GRN (Fig. 4).
Tissue-specific enhancers have been
invaluable for investigation of the genetic
program underlying neural crest forma-
tion and can be exploited in several dif-
ferent contexts. This is exemplified by
numerous studies that have taken ad-
vantage of the mouse Wnt1 enhancer to
address the contribution, potential, and
genetic regulation of the neural crest.
This enhancer region, which is a 5.5-kb
element at the 39 region of the Wnt1 lo-
cus, activates transcription in the dorsal
neural tube and migrating neural crest
cells of murine embryos (Echelard et al.
1994). It has been employed extensively
in mapping the contribution of different
neural crest populations ( Jiang et al.
2000; Nakamura et al. 2006; Barraud et al.
2010) through the use of the Rosa26 sys-
tem (Soriano 1999). It has also been
employed for targeted genetic manipula-
tion through conditional knockout ani-
mals (Ito et al. 2003; Akiyama et al. 2004;
Brewer et al. 2004; Dudas et al. 2004;
Nakamura et al. 2006) that have genes
inactivated specifically in the neural
crest. This has allowed for the functional
characterization of a number of genes in
a neural crest cell-autonomous manner.
The initial approach for the identi-
ficationof enhancers of neural crest genes
was done by screening noncoding DNA
isolated from the locus of the gene of in-
terest (Fig. 4; Echelard et al. 1994). Frag-
ments from the noncoding DNA were
cloned upstream of a minimal promoter
plus reporter sequence and tested in vivo
or in vitro. The sheer size of the genetic
loci and number of subregions that had to
be tested made this approach laborious
and time consuming, particularly given
the time and expense of usingmice. New genomic tools have since
emerged and revolutionized the way cis-regulatory modules are
identified. Importantly, the sequencing of complete genomes has
greatly benefited the search for conserved cis-regulatory elements
(Cooper and Sidow 2003; Uchikawa et al. 2004). Comparison of
the noncoding regions between multiple species has proved an
efficient approach for uncovering evolutionarily conserved re-
gions (ECRs) that may regulate transcription of neighboring genes
(Uchikawa et al. 2003; Betancur et al. 2010b; Simo˜es-Costa et al.
2012). The activity of the ECRs subsequently can be investigated
by stable or transient transgenesis. In this context, the chicken
embryo has proved to be an excellent amniote model for cis-reg-
ulatory analysis in higher vertebrates, due to highly efficient
transient transgenesis accomplished through electroporation
techniques (Sauka-Spengler and Barembaum2008; Takemoto et al.
2011). Similarly, tol2-mediated transgenesis in zebrafish is an ef-
Figure 3. Cranial neural crest gene regulatory network (GRN). The neural crest gene GRN is com-
posed of different regulatory modules arranged hierarchically. Each regulatory state defines cell identity
and behavior at a given time and also drives the transition to the next level of the network. This is
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ficient way to test enhancers, including those that work across
distant species (Fisher et al. 2006; Rada-Iglesias et al. 2012).
A number of neural crest-specific enhancers have been iden-
tified in the past few years in different model organisms. Com-
parative genomics was used to identify neural crest-specific en-
hancers for Zic3, Sox9, Foxd3, Sox10, Snai2, and Twist, among
others (Smith et al. 1997; Bagheri-Fam et al. 2006; Betancur et al.
2010b; Garnett et al. 2012; Simo˜es-Costa et al. 2012). For example,
cis-regulatory analysis of murine Pax3 revealed intriguing aspects
of how neural crest genes are regulated. This analysis uncovered
two distinct enhancers that are capable of driving very similar
neural crest-specific expression. Mutation of either region by itself
does not disrupt gene expression, and thus these enhancers con-
stitute an interesting case of redundancy at the cis-regulatory
level (Milewski et al. 2004; Degenhardt et al. 2010). The lack
of similarity between the two regions also suggests that they re-
quire different inputs, highlighting not only the complexity of
the regulatory code but also the necessity for thorough analysis of
the cis-regulatory apparatus (Degenhardt et al. 2010). Similar to the
case in mice, a study in zebrafish by Garnett and colleagues shows
that the zebrafish pax3a gene expression is also controlled by two
distinct enhancers. Although manipulations in BMP, Wnt, and
FGF signaling disrupt the activity of the individual enhancers,
when combined in the same construct, they are less susceptible to
environmental perturbations. Thus, synergistic activity of differ-
ent regulatory modules can bring a level of robustness to tran-
scriptional control, particularly in the case of genes downstream
from signaling pathways (Garnett et al. 2012).
Tissue-specific enhancers for neural crest derivatives have also
been identified. For example, evolutionarily conserved regions of
the geneMef2c (Agarwal et al. 2011), and tyrosinase-related family
member Tyrp1 (Murisier et al. 2006), can drive specific reporter
expression in melanocytes. Interestingly, both enhancers seem to
be regulated by the transcription factor Sox10, a key regulator of
the melanocytic lineage. Similarly, a Hoxb3 enhancer that is active
in the vagal neural crest drives reporter expression in the enteric
Figure 4. Strategies for cis-regulatory analysis of the neural crest. (A) Early approaches for identifying enhancers of neural crest genes included screening
long stretches of noncoding DNA. Fragments from the locus of the gene of interest were cloned upstream of a minimal promoter and a reporter gene and
tested in vivo by cell transfection or transgenesis. (B) Sequencing of vertebrate genomes facilitated the search for cis-regulatory modules. Computational
comparison between different species reveals evolutionary conserved regions (ECRs) that are putative regulators of nearby genes. The ECRs are sub-
sequently tested for activity by stable or transient transgenesis in different model organisms. (C ) Novel approaches allow for genome-wide analysis of the
cis-regulatory modules. Profiling of histone modification through ChIP-seq allows mapping of chromatin mark patterns and identification of active and
poised enhancers. This method was used to annotate enhancers that are active in human neural crest cells induced from human embryonic stem cells
(Rada-Iglesias et al. 2012). Once enhancers are validated in vivo, they become valuable tools that can be exploited in different contexts. (MP) Minimal
promoter; (REP) reporter gene; (TF) transcription factor.
Genomic approaches in neural crest biology
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nervous system (Chan et al. 2005). Such regulatory modules are
useful tools for targeted functional studies, particularly in chicken
and zebrafish embryos, given the new approaches for efficient and
rapid integration of transgenes in these embryos (Fisher et al. 2006;
Yokota et al. 2011).
Cis-regulatory analysis can also provide insights into how
differences between distinct neural crest populations arise. The cis-
regulatory analyses of both SOX10 (Betancur et al. 2010b) and
FOXD3 (Simo˜es-Costa et al. 2012) point to distinct genetic programs
controlling gene expression at different axial levels of the chick
embryo. Although both SOX10 and FOXD3 are pan-neural crest
markers, different enhancers are responsible for driving transcrip-
tion in the cranial versus trunk neural crest populations. Further-
more, cranial and trunk enhancers are activated by different inputs
(Simo˜es-Costa et al. 2012), which suggests an intrinsic heteroge-
neity in the neural crest population that precedes specification. For
example, two enhancers, NC1 and NC2, were uncovered, which
collectively drive reporter expression that recapitulates the en-
dogenous pattern of FOXD3 in the neural crest but separately
control expression in nonoverlapping neural crest populations.
NC1 drives initial expression in the cranial neural crest but is not
active in the trunk region. In contrast, NC2 mediates initial ex-
pression in trunk neural crest and only drives reporter expression
later in migrating cranial crest cells that no longer have NC1 ac-
tivity. Whereas PAX7 and MSX1/2 are common inputs to both
NC1 and NC2, ETS1 is a direct input into NC1 and ZIC1 into NC2.
Consistentwith axial level specific inputs, ETS1 is a cranial-specific
transcription factor, whereas ZIC1 is expressed in a graded fashion,
from posterior to anterior along the body axis (Simo˜es-Costa et al.
2012). This differential regulation is consistent with the differences
observed in the migratory patterns, potential, and behavior of the
trunk versus cranial neural crest cells (Le Douarin and Kalcheim
1999). Further characterization of unique regulatory modules in
distinct neural crest subpopulations hold the promise of providing
important insights into neural crest heterogeneity and develop-
mental potential.
Currently, an array of new technologies allows high-
throughput identification of cis-regulatorymodules. In the future,
these will allow a systems biology-level analysis of gene regulation
during neural crest formation. Importantly, novel approaches such
as ChIP-seq allow for genome-wide analysis of the cis-regulatory
apparatus at specific times and axial levels, promising to yield new
insight into the regulatory events underlying neural crest de-
velopment. This technique can be used to map the genome-wide
occurrence of histone modifications as well as active binding sites
for transcription factors and coactivators (Valouev et al. 2008;
Creyghton et al. 2010). In a remarkable effort to describe the epi-
genomic landscape of neural crest cells, Rada-Iglesias et al. (2012)
mapped the chromatin mark patterns and transcription factor
occupancy in induced neural crest cells produced from human
embryonic stem cells. This study identified TFAP2A and nuclear
receptors NR2F1 and NR2F2 as key players in neural crest de-
velopment, as the regulators occupy active enhancers character-
ized by high levels of EP300 and H3K27ac occupancy (Rada-Iglesias
et al. 2012). It also revealed thousands of active enhancers func-
tioning during neural crest development. Moreover, the result-
ing epigenomic annotation of these cells constitutes an invalu-
able resource for further investigation of the neural crest genetic
program.
Such studies provide a wealth of information and highlight
the extraordinary complexity of the regulatory events controlling
neural crest formation. Not surprisingly, new paradigms are cur-
rently emerging in the field of gene regulation that may reshape
our views of the neural crest gene regulatory network and bring an
extra layer of complexity to the proposed regulation of this cell
population. Increasing evidence indicates that a complete un-
derstanding of transcriptional events will require taking into
consideration nuclear architecture and dynamics (Cremer and
Cremer 2001; Mateos-Langerak et al. 2007). In the context of the
neural crest, a recent study has shown that mutations of histone
H3.3 cause down-regulation of neural crest specifiers and loss
of crest-derived ectomesenchyme (Cox et al. 2012). This is par-
ticularly interesting since the H3.3 variant histones tend to be as-
sociated with permissive chromatin structures and have been
described as regulators of transcription and specification of germ
cells. The results highlight how chromatin rearrangements can
impact the transcriptional state of the neural crest and their im-
portance for its developmental potential (Cox et al. 2012). In-
terestingly, transcription factors also have been shown to interact
with repressive molecules involved in epigenetic silencing (Wang
et al. 2011; Strobl-Mazzulla and Bronner 2012). Thus, increasing
evidence points to a new paradigm in which transcription factor
complexes are constantly rearranging chromatin structure, result-
ing in dynamic shifts of the regulatory state.
The development of novel techniques such as ChIA-PET, 5C,
and Hi-C have allowed the identification of transcription factor
modules that are comprised of trans-regulators complexed with
different cis-regulatory regions and transcription start sites (Sanyal
et al. 2011; Lan et al. 2012). These innovative approaches allow for
the characterization of chromosome looping, interaction between
different enhancers and promoter regions, and provide a three-
dimensional assessment of the state of transcriptional regulation.
Recent studies using chromosome conformation capture carbon
copy (5C) in different human cell lines have pointed to a large
number of long-range interactions between enhancers and pro-
moters and indicate that only a minority of such interactions occur
with the nearest gene (Sanyal et al. 2012). Furthermore, ChIA-PET
analysis highlights a large number of promoter–promoter inter-
actions between often-distant genes, suggesting the formation of
multigene complexes that are coregulated by the same transcrip-
tional machinery (Li et al. 2012). These findings infer a different
model of gene regulation in which promoters and enhancers co-
alesce in transcription ‘‘factories’’ assembled at particular compart-
ments in the nuclei (Sandhu et al. 2012). Such emerging concepts in
eukaryotic gene regulation will surely impact how the neural crest
genetic program is interpreted and scrutinized in the years to come.
Evolutionary conservation of the neural crest GRN
The neural crest gives rise to a number of vertebrate-specific features
such as the craniofacial skeleton and peripheral nervous system. As
a vertebrate synapomorphy, neural crest cells are thought to have
been crucial for the early evolution of vertebrate body plan and
predatory lifestyle. This idea was put forward in the ‘‘New Head’’
hypothesis by Gans and Northcutt, which postulated that the
emergence of neural crest derivatives allowed for remodeling of the
chordate head and resulted in a shift from filter feeding to active
predation (Gans and Northcutt 1983). Although the main premise
of the New Head hypothesis is still supported by evidence from the
fossil record and developmental studies, tracing the origin of the
neural crest to an invertebrate precursor cell type has proven to be
a challenge, as invertebrate chordates lack migratory cells that are
formed at the neural plate border (Northcutt 2005; Hall and Gillis
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neural crest and its putative evolutionary precursors holds the
promise of shedding light on the evolutionary origins of the verte-
brate neural crest.
Genomic studies have been key in informing scenarios that
attempt to explain the origins of neural crest and its role in ver-
tebrate evolution. Sequencing of chordate genomes allowed for the
systematic characterization of expression and function of the
neural crest GRNhomologs in the chordate lineage (Yu et al. 2008).
Studies from basal vertebrates such as the lamprey have offered
interesting insights pertaining to the origin and evolution of the
neural crest (Sauka-Spengler et al. 2007). Finally, whole genome
phylogenetic analysis also has had considerable impact on how
vertebrate evolution and neural crest evolution are surveyed.
Molecular phylogenetic studies have placed tunicates as sister
groups of vertebrates (Philippe et al. 2005; Delsuc et al. 2006) and
also pointed to a potential role for genome-wide duplications in
facilitating the origins of the neural crest (Green and Bronner
2013).
The use of the lamprey Petromyzon marinus as a model or-
ganism has provided important information about the ancestral
state of the neural crest. Lampreys are basal vertebrates that lack
several neural crest derivatives, including a neural crest-derived
jaw and sympathetic ganglia (Nicol 1952; Ha¨ming et al. 2011).
Nevertheless they possess a SoxE expressing population of mi-
grating neural crest cells (McCauley and Bronner-Fraser 2006) that
contribute to branchial arch cartilage, as well as the formation of
pigment cells, cranial, and dorsal root ganglia. In an extensive
analysis of the lamprey neural crest genetic program, Sauka-
Spengler et al. (2007) described the expression patterns of ortho-
logs of numerous genes occupying different hierarchical positions
within the neural crest GRN. The results from this study defin-
itively show conservation of most of the neural crest genetic pro-
gram in this basal vertebrate with genes maintained in the same
spatial and temporal relationships as those observed in jawed
vertebrate models (Sauka-Spengler et al. 2007). This was corrobo-
rated by functional studies demonstrating that the epistatic re-
lationships between neural plate border genes and neural crest
specifiers are largely conserved (Nikitina et al. 2008). Although
these results point to a strong conservation of the neural crest GRN
across vertebrates, some intriguing differences have emerged from
this work. For example, the neural crest specifier Twist, which is
thought to be crucial in the acquisition of the mesenchymal state
in higher vertebrates, is only expressed in lampreyneural crest cells
at a later time, when they populate the branchial arches rather
than within the ‘‘neural crest specifier’’ module. Similarly, Ets1,
which acts as a critical neural crest specifier gene in jawed verte-
brates, functioning directly upstream of both Sox10 and Foxd3, is
only employed in the effector module in the lamprey GRN (Sauka-
Spengler et al. 2007; Sauka-Spengler and Bronner-Fraser 2008c).
Such differences suggest that shifts in the circuitry of the specifier
module within the neural crest GRN might result in species-spe-
cific traits.
Since comparative genomic analyses support the position of
tunicates as the sister group of vertebrates, Ciona intestinalis or other
ascidians now occupy a key phylogenetic position for examining
theorigins of vertebrate features (Schubert et al. 2006). Studies of the
development of the ascidian, Ecteinascidia turbinate, led to the
identification of pigmented cells from the A7.6 lineage that arises
near the neural tube and undergoes migration ( Jeffery et al. 2004).
This cell lineage, which is known as the trunk lateral cells, expresses
the HNK-1 epitope as well as the Twist, FoxD, AP2, and Myc ortho-
logs ( Jeffery 2006; Jeffery et al. 2008). Further studies are necessary
to determine unequivocally if these cells are derived from theneural
plate border, neural tube, or other tissue (Hall andGillis 2013). In an
intriguing recent study, Abitua et al. (2012) showed that a lineage
a9.49 in Ciona intestinalis expresses ID, Snail, ETS, and FoxD, as well
as melanogenic genes like MITF, TYR, and TYRP. This lineage nor-
mally contributes to the formation of the otolith and the ocellus
and does not migrate extensively. However, misexpression of Twist
causes these cells to adopt a mesenchymal fate and exhibit long-
range migration (Abitua et al. 2012). Because these lineages share
some common gene signatures with vertebrate neural crest cells,
they may hold important clues to neural crest origins.
The expression of neural crest orthologs also has been in-
vestigated in the amphioxus (Branchiostoma floridae) (Meulemans
and Bronner-Fraser 2002; Meulemans et al. 2003; Yu et al. 2008),
a cephalochordate. Although the amphioxus body plan shares
important morphological traits with vertebrates, molecular phy-
logeny has now placed cephalochordates at the base of the chor-
date tree (Philippe et al. 2005). A systematic analysis of neural crest-
related genes indicates conservation of specification mechanisms
at the neural plate border between cephalochordates and verte-
brates. The transcription factor Snail is expressed specifically in the
lateral portion of the neural tube in the neurula, althoughno other
neural crest-specifier genes are coexpressed at this location (Yu
et al. 2008). Thus, it is tempting to speculate that this transient
expression of Snail may reflect the beginnings of the assembly of
a neural crest-specifier module.
Co-option of regulatory elements is likely to have played an
important role in the origins of the neural crest in the vertebrate
lineage. As an example, Manzanares et al. (2000) performed
transgenesis experiments in which they expressed cis-regulatory
regions encoding amphioxus Hox gene expression in vertebrates.
Surprisingly, despite the fact that amphioxus lacks neural crest,
these enhancers drove spatially localized expression in vertebrate
neural crest and placode derivatives like cranial ganglia and bran-
chial arches (Manzanares et al. 2000). This study demonstrates that
cis-regulatory elements capable of driving gene expression in
neural crest cells are already present in the cephalochordate ge-
nome. Such elements might have been co-opted to control ex-
pression of neural crest-specifier genes, thereby facilitating emer-
gence of this cell type.
Although invertebrate cell lineages described above share
some regulatory and behavioral traits with the neural crest, it is
difficult to ascertain their positionwith respect to the evolutionary
precursors of neural crest cells. If one defines the neural crest by
virtue of its specification kernel, that is, the network module that
comprises the neural crest specifier genes, then a bona fide neural
crest must have factors that control multipotency, EMT, and di-
verse lineage specification. As highlighted by Davidson (2009),
there are numerous instances in which a given regulatory gene
functions in different levels of the GRN, often within the com-
mitment and differentiation of the same cell type. This is observed
repeatedly in neural crest development with genes such as Foxd3,
SoxE, andMsx1/2, being employed early for specification purposes,
and again later to activate differentiation of various cell types (e.g.,
melanocytes, cartilage, and neuronal cell types). Further work will
be necessary to define whether the regulatory similarities observed
between neural crest cells and intriguing lineages in invertebrate
chordates are a consequence of conservation of ancient differen-
tiation programs or if they indeed are part of the novel regulatory
module that characterizes the neural crest.
Taken together, these studies indicate that the proximal levels
of the neural crest gene regulatory network, such as induction of
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the neural plate border, are primitive features shared amongst
chordates, whereas the core neural crest specification modules of
the network might have been added during early vertebrate evo-
lution. This is expected since delimitation of the neural plate
border is necessary for development of the central nervous system.
The terminal differentiation programs of the neural crest GRN also
are deeply conserved in both cephalochordates and tunicates,
particularly the control of pigment cell differentiation (Yu et al.
2008; Davidson 2009). This is not surprising as most of the dif-
ferentiation batteries are thought to be ancient (Davidson 2009).
Placement of the origin of the specification kernel of the GRN still
demands further studies, but it is clear that it has a high degree of
conservation among vertebrates, as supported by studies in the
lamprey (Sauka-Spengler et al. 2007; Sauka-Spengler and Bronner-
Fraser 2008a).
Neural crest cells and disease
The above data show that scrutinizing the regulatory mechanisms
controlling neural crest formation can expand our understanding
of essential cellular processes such as delamination,migration, and
differentiation, as well as shed light on important evolutionary
questions pertaining to vertebrate origins and adaptation. Be-
yond its relevance for basic biological questions, the neural crest
is also of remarkable medical importance for its role in birth de-
fects and malignant diseases. Studies on the plasticity of the
neural crest and its fate switches also offer clues for strategies for
cell reprograming and stem cell manipulation. In addition, the
persistence of neural crest stem cells in adult tissues offers po-
tential targets for therapies aiming to utilize endogenous pro-
genitors for repair and regeneration.
Given the sheer number of cell types and derivatives formed
by the neural crest progenitor cell population and the complexity
of its developmental program, it is not surprising that a large
fraction of congenital birth defects can be traced back to the neural
crest (Hall 1999). Neural crest developmental anomalies, or neuro-
cristopathies, are responsible for the vast majority of craniofacial
malformations, and more than 700 different syndromes have
been described (Trainor 2010). In addition to the skeletal ele-
ments of the face, abnormal neural crest development can also
affect the heart, adrenal medulla, pigment cells, and the periph-
eral nervous system. Although treatment of neurocristopathies
has improved considerably over the years, dissection of the mo-
lecular mechanisms underlying many of these disorders could
bring considerable improvements to management and preven-
tion of these conditions.
In the past few decades, the molecular basis of several neural
crest-related syndromes has been investigated through genetic
linkage as well as the use of animal models. One example is
Treacher Collins disease, an autosomal dominant disorder that is
marked by severe hypoplasia of skeletal elements of the face and
irregularities in otic and ophthalmic development (The Treacher
Collins Syndrome Collaborative Group 1996; Trainor 2010). Ge-
netic mapping and gene expression analysis identified mutations
in the Tcof1 gene as the cause of the disease. Mapping of TCOF1
expression in mouse embryos shows that it is enriched in neural
crest cells and facialmesenchyme, raising the intriguing possibility
that the mutations could be interfering with neural crest de-
velopment (Dixon et al. 2006). In fact, TCOF1 is important for ri-
bosome biogenesis and disruption of this process results in TP53-
mediated apoptosis, and analysis of Tcof1 null mice reveals strong
reduction in the migratory neural crest population as a conse-
quence of increased apoptosis and reduced proliferation of mi-
grating cells (Dixon et al. 2006).
Genomic approaches have greatly benefited the dissection of
mechanisms leading to congenital disease. Genome-wide associa-
tion studies have been pivotal to the identification of a number of
loci and genetic variants associated to craniofacial anomalies
(Grant et al. 2009; Beaty et al. 2010; Mangold et al. 2010; Dixon
et al. 2011) and also suggest genes linked to normal variation in
facial structure (Liu et al. 2012). Similarly, recent studies using
exome sequencing have been used to map the causes of craniofa-
cial defects in conditions such as Miller syndrome (Ng et al. 2010)
and Nager syndrome (Bernier et al. 2012). Current transcriptome
and epigenomic analysis should accelerate the dissection of the
genetic basis of neural crest-related syndromes through regulatory
network comparisons between normal and disease states. Such
studies promise to uncover more complex aspects of disease such
as variable penetrance and multifactorial etiology. In this context,
centralized databases of genomic information containing data sets
of high-throughput studies such as Facebase and ENCODE will be
key (The ENCODE Project Consortium 2004; Hochheiser et al.
2011). Such integrated databases and user-friendly bioinformatic
software will become increasingly important in the neural crest
field as it continues to shift toward genomic approaches.
The medical importance of neural crest cells is not restricted
to congenital birth defects. This cell population has an important
link to metastatic conditions due to its migratory and invasive
properties. Neural crest-derived cancers, such as melanoma and
neuroblastomas, tend to be particularly aggressive and prone to
metastasis. This has led to the assumption that malignancy in
neural crest-derived cell types involves the reactivation of regula-
tory circuits important for embryonic development but that are
normally silenced once cell differentiation has occurred. Indeed,
evidence from studies of malignant melanoma cell lines shows
anomalous transcriptional reactivation of genes such as Snai,
Twist, Sox10, and Myb, all of which are important neural crest
specifier genes in the early GRN (Shakhova et al. 2012; Shirley et al.
2012; Weiss et al. 2012). Interestingly, transplanting melanoma
cells to chicken embryo causes ‘‘regulation’’ of some of the cells
that migrate along neural crest pathways, although some do lo-
calize in ectopic sites (Kulesa et al. 2006). This suggests that mel-
anoma cells can respond to cues in the embryonic environment
similar to neural crest cells. Thus, the embryonic environmentmay
be able to control or inhibit the metastatic state (Hendrix et al.
2007), at least under some circumstances. Although this is an in-
triguing possibility, further work that compares the genetic pro-
grams controlling neural crest and neural crest-derived tumor cells
is needed to inform upon the link between neural crest de-
velopment and metastatic behavior in malignant cells.
The neural crest has also been an important model for the
study of EMT, which is central for metastatic processes. Awealth of
knowledge regarding the genetics and cell biology underlying EMT
has been obtained through the use of the neural crest as a model
(Barrallo-Gimeno and Nieto 2005; Lee et al. 2006; Yang and
Weinberg 2008; Acloque et al. 2009). Interestingly, recent evidence
suggests that cells undergoing EMT seem to acquire stem-like
properties. Induction of EMT in different cell lines has been shown
to up-regulate totipotencymarkers such as POU5F1 (also known as
OCT4) and NANOG in conjunction with transition to a mesen-
chymal state (Mani et al. 2008). Such findings highlight similari-
ties between the metastatic process and neural crest development.
They also point to interconnectivity between cell behavior and
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assembly of the neural crest regulatory network will highlight
common nodes in the genetic circuits controlling EMT, plasticity,
and migratory potential. Such events are likely to depend on the
shared regulatory circuits that interconnect to define neural crest
identity.
The question of plasticity has been central to neural crest bi-
ology, and interest in the topic of self-renewal and developmental
potential has driven efforts to isolate neural crest stem cells. Work
by several investigators has led to the identification and purifica-
tion of neural crest stem cells—cells with the potential to self-
renew and also to give rise to the diverse population of derivatives
that are generated by the neural crest. The first neural crest pro-
genitor cells were isolated in vitro by clonal analysis of quail cells
and shown to be multipotent (Sieber-Blum and Cohen 1980). The
ability of neural crest cells to self-renew was first demonstrated in
elegant studies by Stemple and Anderson using clonal cultures of
murine neural crest cells purified by cell sorting based on expres-
sion of the NGFR (p75) cell surface epitope (Stemple and Anderson
1992, 1993). These cells have the ability to self-renew and also to
form neurons or glia, thus demonstrating true stem cell properties.
More recently, clonal analysis of cranial neural crest in quail has
revealed that this population has the potential to differentiate into
osteoblasts (Calloni et al. 2009), and that the majority of the cra-
nial neural crest is comprised of progenitors with both osteogenic
and neural-melanocytic potential. Remarkably, this study also
identified precursors that can give rise to all neural crest-derived
phenotypes analyzed, which indicates that part of the migratory
cranial crest remains multipotent (Calloni et al. 2009). Although
isolated neural crest stem cells represent a good model for studies
of plasticity and commitment, there are possible caveats. Because it
is likely that in vitro culture conditions introduce changes that do
not reflect in vivo behavior, embryological observations of these
cells in their normal environment will be critical to uncovering the
mechanism underlying maintenance and renewal of the latent
neural crest stem cell population.
Neural crest-like cell populations have been derived from
human embryonic stem cells by a number of different methods
(Chimge and Bayarsaihan 2010). For instance, neural crest cells
were isolated from neural rosettes through fluorescence activated
cell sorting (FACS) using markers NGFR (p75) and B3GAT1 (pre-
viously HNK1,) and subsequently express neural crest specifiers,
such as SOX10 and SNAI1 (SNAIL). These have been shown to
differentiate into awide range of neural crest derivatives, including
sensory and autonomic neurons, Schwann cells, myofibroblasts,
adipocytes, cartilage, and bone cells (Lee et al. 2007). Another
study identified early migrating neural crest cells in neurospheres
cultured on fibronectin plates. These cells express the neural crest
specifier SOX10 and clonal analysis indicates they are multipo-
tent. Importantly, when these cells are injected in chick embryos,
they migrate normally and contribute to the same derivatives as
endogenous neural crest cells (Curchoe et al. 2010).
Induced neural crest cells (iNCCs) from biopsied human tis-
sue may be useful in different contexts for clinical purposes. First,
iNCCs can be used as a model for the study of human neuro-
cristopathies, as cells from patients can be reprogrammed to adopt
a neural crest fate (Lee et al. 2009). This approach essentially allows
the observation of an embryonic cell population from repro-
grammed adult cells, which can be used for transcriptomic, epi-
genomic, or behavioral investigations that can uncover molecular
mechanisms of disease and possibly also expand our knowledge of
the neural crest gene regulatory network. There is also the promise
that induced neural crest cells could be used for cell therapy for
diseases that involve failure or impairment of neural crest-derived
tissue (Crane and Trainor 2006; Barraud et al. 2010). For instance,
transplantation of induced ‘‘neural crest-like cells’’ to diabeticmice
resulted in improvement of the impaired nerve and vascular
functions that result fromdiabetic neuropathy (Okawa et al. 2012).
Onewould imagine that engineered neural crest cells could be used
in such fashion to treat neurodegenerative disorders that affect
peripheral nervous system, among others.
Although it is clear that iNCCs are a powerful tool that can
reveal novel molecular mechanisms and hold promise in treat-
ment of disease, it is important to bear in mind that neural crest
development is intrinsically linked to the embryonic environ-
ment. In vitro conditions do not necessarily reflect the complexity
and dynamism of a developing embryo and thus are unlikely to
recapitulate in vivo conditions. This is especially true for the neural
crest, which is continuously interacting with different cell types
and embryonic environments. Therefore, in vivo approaches con-
tinue to represent the gold standard for neural crest biology, and
findings obtained with isolated neural crest cells or iNCCs should
be validated with model organisms when possible.
Conclusions
Over one hundred years of investigation of the neural crest has
produced a remarkable body of knowledge about neural crest cell
behavior, derivatives, and plasticity. The ingenuity and creativity of
classical embryologists helped to frame the very questions that re-
main integral to the field of neural crest biology today. The in-
troduction of recombinantDNA technology in the 1990s has finally
allowed these questions to be addressed at the mechanistic level by
analysis of the components of the genetic machinery that imbues
the neural crest with its fascinating properties. In the last twenty
years, several aspects of the genetic circuitry controlling these cells
have been identified and functionally characterized, providing im-
portant insights into the logic of neural crest development.
Yet we are still at the ‘‘tip of the iceberg’’ in terms of under-
standing this intriguing cell population from an integrated geno-
mic perspective. Further transcriptome and enhancesome analysis
of neural crest cells at various stages and states of development will
greatly increase our understanding of the neural crest GRN. Since
regulatory states are dynamic and interconnected, this should be
expanded to encompass more axial levels and time points of de-
velopment, ranging from the neural plate border to the final dif-
ferentiated state. The formulation of computational models that
can predict outcomes within the GRN and account for species-
specific differences across vertebrates hold the promise of greatly
increasing our understanding of deuterostome evolution (Peter
et al. 2012). Finally, additional levels of control have been shown
to act in the control of neural crest behavior and identity, including
epigenetic (Hu et al. 2012), post transcriptional ( Jayasena and
Bronner 2012), and post-translational regulation (Lee et al. 2012).
Future research along these lines has the potential to reveal the se-
crets of the neural crest from its inception at the neural plate border
to their acquisition of specific differentiated fates.
Another exciting feature of the neural crest is its position at
the convergence of developmental, cancer, and stem cell biology.
As such, neural crest cells serve as a model for the investigation of
processes as diverse as the epithelial to mesenchymal transition, to
cell motility and migration, and transition from stemness to the
differentiated state. Genomic analyses provide tools and insights
that are poised to reveal the complexities of these events with
unprecedented depth and breadth. Given the inherent inter-
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connections that exist between diverse biological processes, the
neural crest represents an excellent model system for unbiased
examination of the genetic basis of cellular identity and behavior.
In turn, the results of these studies will undoubtedly have im-
plications for other aspects of stem cell biology and metastatic
transformation.
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